Regeneron Pharmaceuticals, Inc. <REGN.O>: BMO Raises Target Price to $920 From $800
REGN•Related News
Heartflow highlights 2Q26 revenue up 48% YoY to $64.1 million in investor presentation
HTFL•
Jefferies Credit Partners targets $4 billion European direct lending capacity with inaugural fund close
JEF•
Mexico annual inflation rate was 3.26% in August
EWW•
Abacus Global Management participates in Barclays Global Financial Services Conference
ABL•
Academy Sports Q2 FY26 GAAP EPS rises 17.3% to $2.17; net sales increase 3% to $1.65 billion
ASO•